Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer

Clinical trial NCT00365391 · COMPLETED

Trial details

NCT number: NCT00365391
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer

Start date: 2006-08-01
Primary completion: 2008-08-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.